Status:
COMPLETED
Contralateral R1 in Amyotrophic Lateral Sclerosis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18-99 years
Brief Summary
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting both upper and lower motor neurons. Electroneuromyography is an important tool for the diagnosis. Previous studies have sho...
Eligibility Criteria
Inclusion
- For patients
- Aged 18 to 99 years old
- Referred for suspected motor neuromuscular disease
- Collection of non-opposition
- For healthy subjects:
- Aged 18 to 99 years old
- Absence of any neurological pathology
- Collection of non-opposition
Exclusion
- Previous damage linked to another cause of the cranial nerves
- Prior brainstem lesions
- Persons deprived of liberty by a judicial or administrative decision
- Patient under judicial protection, unable to express consent
Key Trial Info
Start Date :
February 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 5 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06206629
Start Date
February 15 2024
End Date
September 5 2024
Last Update
October 9 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital neurologique Pierre Wertheimer
Bron, Rhone, France, 69500
2
CHU de Nantes
Nantes, France, 44093